Jaipur, India, 302019
ORAVERSE M is a scientifically developed health supplement containing Myo-inositol (600 mg) and Metformin Hydrochloride (500 mg), specifically created to enhance metabolic function, particularly for those with polycystic ovary syndrome (PCOS) and insulin resistance. This combination targets hormone equilibrium, glucose processing, and ovarian activity, delivering a thorough approach to enhancing reproductive and metabolic health. It's frequently prescribed within treatment protocols for women with PCOS or individuals experiencing challenges with insulin response and irregular ovulation. Core Components: Myo-inositol IP (600 mg): A vitamin-like compound (related to B vitamins) that plays an essential role in cell signaling, particularly insulin signal pathways. It's recognized for its beneficial impact on ovarian health, hormone balance, and metabolic regulation. Metformin Hydrochloride (500 mg): An established diabetes treatment that reduces blood glucose and enhances insulin effectiveness. It's commonly used for Type 2 diabetes mellitus and PCOS-related insulin resistance. Principal Benefits: Improves Insulin Effectiveness: Both Myo-inositol and Metformin collaborate to boost insulin response and decrease insulin resistance, a crucial factor in metabolic conditions and PCOS. Normalizes Menstrual Cycles & Ovulation: Particularly advantageous for PCOS patients, ORAVERSE M may help stabilize menstrual patterns and enhance ovulation. Improves Ovarian Health: Myo-inositol supports follicle growth and egg quality, potentially improving fertility prospects. Minimizes Excess Androgen Effects: Helps reduce symptoms like acne, excessive hair growth, and hair thinning resulting from elevated androgen levels in PCOS. Facilitates Weight Control: Enhances metabolic factors that contribute to better weight management, especially in people with insulin resistance. Decreases Type 2 Diabetes Risk: By improving glucose control and lowering insulin levels, this formula may help prevent progression to diabetes. Mode of Action: ORAVERSE M operates through a two-pronged approach: Myo-inositol enhances insulin signaling within cells, supporting glucose uptake and processing. It also influences luteinizing hormone (LH) and follicle-stimulating hormone (FSH) regulation, helping restore hormone balance critical in PCOS. Metformin Hydrochloride limits liver glucose production and increases insulin sensitivity in muscle and fat tissues, resulting in improved blood sugar management. For women with PCOS, Metformin also helps normalize menstrual cycles and ovulation. Together, these ingredients work to restore metabolic and reproductive wellness by addressing the fundamental causes of PCOS and related metabolic dysfunctions. Usage Instructions: Typical Dosage: One ORAVERSE M tablet is usually taken once or twice daily, as prescribed by a healthcare provider. Consumption Method: Take with food to minimize stomach discomfort. Swallow whole with water—don't crush or chew. Important: Always follow your doctor's specific recommendations for dosage and treatment duration. Possible Side Effects: ORAVERSE M is generally well-tolerated, though some users may experience reactions, particularly when beginning treatment: Common Reactions: Nausea Bloating or gas Mild diarrhea Stomach discomfort Metallic taste (Metformin-related) Less Common but Significant: Vitamin B12 deficiency (with long-term Metformin use) Mild dizziness or headache Low blood sugar (rare, especially when combined with other diabetes medications)
| Composition | Myo-inositol IP (600 mg), Metformin Hydrochloride (500 mg) |
| Dosage | As Directed By the Physician |
| Country of origin | INDIA |
| Manufactured By | Steris Healthcare Pvt Ltd |
| Storage | Store In A Cool & Dry Place |
| Packaging Size | 15 Tablets |
| Brand Name: | ORAVERSE M |